Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EBIT Growth(%) 5.01-10.2120.685.2614.20

What is the latest EBIT Growth ratio of LINCOLN PHARMACEUTICALS ?

The latest EBIT Growth ratio of LINCOLN PHARMACEUTICALS is 5.01 based on Mar2026 Consolidated results.
Year EBIT Growth
Mar20265.01
Mar2025-10.21
Mar202420.68
Mar20235.26
Mar202214.20

How is EBIT Growth of LINCOLN PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2026 5.01
Positive
Mar2025 -10.21
Negative
Mar2024 20.68
293.16
Mar2023 5.26
-62.96
Mar2022 14.2 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare EBIT Growth ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,023.9 Cr -6.9% -12.5% -4.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,202.0 Cr 0.5% -2.9% 5% Stock Analytics
DIVIS LABORATORIES ₹264,141.0 Cr 5% 7.2% 49.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹174,402.0 Cr -0.5% -4.5% 28.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,868.0 Cr 2.7% 8.4% 5.1% Stock Analytics
CIPLA ₹111,650.0 Cr 2.4% 2.4% -12.9% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-6.9%

-12.5%

-4.3%

SENSEX

2.8%

4.4%

-10.1%


You may also like the below Video Courses